Lack of effect of fish oil supplementation on coagulation and transcapillary escape rate of albumin in insulin-dependent diabetic patients with diabetic nephropathy

REFERENCES

• Borch-Johnsen K, Kreiner S. Proteinuria—a pre-dictor of cardiovascular mortality in insulin-dependent diabetes mellitus. Br Med J 1987; 294: 1651–4.
   Google Scholar
• Jensen T, Bjerre-Knudsen J, Feldt-Rasmussen B, Deckert T. Features of endothelial dysfunction in early diabetic nephropathy. Lancet 1989; 1: 461–3.
   PubMed Web of Science ®Google Scholar
• Deckert T, Feldt-Rasmussen B, Borch-Johnsen K, Jensen T, Kofoed-Enevoldsen A. Albuminuria reflects widespread vascular damage. The Steno hypothesis. Diabetologia 1989; 32: 219–6.
   PubMed Web of Science ®Google Scholar
• Shimomura H, Spiro RG. Studies on macromolec-ular components of human glomerular basement membrane and alterations in diabetes. Decreased levels of heparan sulfate proteoglycan and laminin. Diabetes 1987; 36: 374–81.
   Google Scholar
• Dybdal H, Ledet T. Diabetic macroangiopathy. Quantitative histopathological studies of the extra-mural coronary artery from type 2 (non-insulin-dependent) diabetic patients. Diabetologia 1987; 30: 882–6.
   Google Scholar
• Wasty F, Alavi MZ, Moore S. Distribution of glycosaminoglycans in the intima of human aortas: changes in atherosclerosis and diabetes mellitus. Diabetologia 1993; 36: 316–22.
   Google Scholar
• Feldt-Rasmussen B. Increased transcapillary escape rate of albumin in type 1 (insulin-depen-dent) diabetic patients with microalbuminuria. Diabetologia 1986; 29: 282–6.
   PubMed Web of Science ®Google Scholar
• Jensen T, Bjerre-Knudsen J, Feldt-Rasmussen B, Deckert T. Features of endothelial dysfunction in early diabetic nephropathy. Lancet 1989; 1: 461–3
   PubMed Web of Science ®Google Scholar
• Bent-Hansen L, Feldt-Rasmussen B, Kverneland A, Deckert T. Plasma disappearance of glycated and non-glycated albumin in type 1 (insulin-dependent) diabetes mellitus: evidence for charge dependent alterations of the plasma to lymph pathway. Diabetologia 1993; 36: 361–3.
   PubMedGoogle Scholar
• Myrup B, Rossing P, Jensen T, Gram J, Kluft C, Jespersen J. Procoagulant activity and intimal dys-function in IDDM. Diabetologia 1995; 38: 73–8.
   PubMedGoogle Scholar
• Jensen T, Stender S, Goldstein K, Balmer G, Deckert T. Partial normalisation by dietary cod-liver oil of increased microvascular albumin leak-age in patients with insulin-dependent diabetes and albuminuria. N Eng J Med 1989; 321: 1572–7.
   Google Scholar
• Rossing P, Hansen BY, Nielsen FS, Myrup B, Balmer G, Parving H-H. Fish oil in diabetic nephropathy. Diabetes Care 1996; 19: 1214–9.
   PubMed Web of Science ®Google Scholar
• Parving H-H, Rasmussen SM. Transcapillary escape rate of albumin and plasma volume in short-and longterm juvenile diabetics. Scand J Clin Lab Invest 1973; 32: 81–7.
   Google Scholar
• Svendsen PA, Christiansen JS, Soegaard U, Welinder BS, Nerup J. Rapid changes in chromato-graphically determined haemoglobin A,c induced by short-term changes in glucose concentrations. Diabetologia 1980; 19: 130–6.
   Google Scholar
• Ranby M, Bergsdorf T, Nilsson T, Mellbring G, Winblad B, Bucht G. Age dependence of tissue plasminogen activator concentrations in plasma as studied by an improved enzyme-linked immuno-sorbent assay. Clinical Chemistry 1986; 32: 160–5.
   Google Scholar
• Declerck PJ, Alessi MC, Verstreken M, Kruithof EKO, Juhan-Vague I, Collen D. Measurement of plasminogen activator inhibitor in biological fluids with a murine monoclonal antibody based enzyme-linked immunosorbent assay. Blood 1988; 71: 220–5.
   Google Scholar
• Pelzer H. Determination of c2-antiplasmin-plasmin complex in human plasma with an enzyme-linked immunosorbent assay. Fibrinolysis 1993; 7: 69–74.
   Google Scholar
• Declerck PJ, Mombaerts P, Holvoel P, De Mol M, Collen D. Fibrinolytic response and fibrin fragment D-Dimer levels in patients with deep vein throm-bosis. Thromb Haemostas 1987; 58: 1024–9.
   Google Scholar
• Amiral J, Adam F, Mimilla F, Chambrette B, Boffa MC. A new assay for soluble forms of thrombomodulin in plasma. Thromb Haemostas 1991; 65: 947–896.
   Google Scholar
• Meijer P, Boon R, Jie AFH, Rosen S, Kluft C. Bioimmunoassay for tissue type plasminogen acti-vator (t-PA) in human plasma. Evaluation of blood sampling and handling procedures and compari-sons with other t-PA activity methods. Fibrinolysis 1992; 6 Suppl 3: 97–9.
   Google Scholar
• Blombäck B, Blombäck M. Preparation of human fibrinogen fraction 1-2. Arkiv Kemi 1956; 10: 415–43.
   Google Scholar
• Ingerslev J. A sensitive ELISA for von Willebrand factor (Vwf:Ag). Scand J Clin Lab Invest 1987; 47: 143–9.
   PubMed Web of Science ®Google Scholar
• Hoy CE, Balmer G. Dietary linoleic acid and the fatty acid profiles in rats fed partially hydrogenated marine oils. Lipids 1988; 23: 973–80.
   PubMedGoogle Scholar
• Brown WB Jr, Hollander M. Statistics. A biomed-ical introduction. New York: John Wiley and Sons, 1977: 333–5.
   Google Scholar
• Blann AD, Tabemer DA. A reliable marker of endothelial call dysfunction: Does it exist. Br J Haematol 1995; 90: 244–8.
   PubMed Web of Science ®Google Scholar
• Meade TW, Mellows S, Brozovic M et al. Haemostatic function and ischaemic heart disease. Principal results of the Northwich Park Heart Study. Lancet 1986; 2: 533–7.
   Google Scholar
• Hamsten A, de Faire U, Walldius G et al. Plasminogen activator inhibitor in plasma: risk factor for recurrent myocardial infarction. Lancet 1987; 2: 3–9.
   PubMed Web of Science ®Google Scholar
• Myrup B, Rossing P, Jensen T, Gram J, Kluft C, Jespersen J. Fibrinolysis in insulin-dependent dia-betic patients with and without nephropathy. Fibrinolysis 1996; 10: 331–5.
   Google Scholar